The BOD at its meeting held today has recommended a final dividend of Rs. 10 per equity share of Rs. 2 each for FY ended 31st March 26 for approval of the shareholders of the Company at ....
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alkem Laboratories Board of Directors met on 28th May 2026 and approved the standalone and consolidated audited financial results for Q4 and FY ended 31st March 2026, with auditors expressing an unmodified opinion. The Board recommended a final dividend of Rs. 10 per equity share of face value Rs. 2 each for FY 2025-26, subject to shareholder approval at the ensuing AGM. The record date for dividend entitlement is fixed as 7th August 2026, with payment to be made from 1st September 2026. The 52nd AGM is scheduled for 27th August 2026 with a cut-off date of 20th August 2026. The Board also approved re-appointment of Mrs. Madhurima Singh as Executive Director for 5 years from 20th December 2026.
The recommended dividend of Rs. 10 per share represents a consistent shareholder reward practice. Shareholders on the record date of 7th August 2026 will receive the dividend from 1st September 2026. The declaration of unmodified financial results signals clean books and may provide positive sentiment for investors.